Nuveen AMT-Free Municipal Credit Income Fund
NVG · NYSE
About NVG
- Employees
- 0
- Headquarters
- Chicago, Illinois
- Listed
- Mar 25, 2002
- Sector
- N/A
- Industry
- N/A
- Website
- nuveen.com
NVG key statistics
- Market cap
- 2.69B
- Price-earnings ratio
- 0.00
- Dividend yield
- 8.79%
- Average volume
- 1.66M
- Volume
- 1.29M
- Open price
- $10.82
- High today
- $10.91
- Low today
- $10.77
- 52 Week high
- $13.59
- 52 Week low
- $10.29
Nuveen AMT-Free Municipal Credit Income Fund (NVG) at a glance
Nuveen AMT-Free Municipal Credit Income Fund (NVG) last traded at $10.79, with a market cap of 2.69B, a price-to-earnings ratio of 0.00 and a dividend yield of 8.79%.
Today the stock has traded between $10.77 and $10.91. The current price is 0.2% above the day's low and 1.1% below its high.
Volume so far is 1.29M shares, below the average of 1.66M shares a day.
Over the past year Nuveen AMT-Free Municipal Credit Income Fund has ranged from $10.29 to $13.59, and now sits 15% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.